Skip to main content
. 2021 Apr 14;320(6):L1147–L1157. doi: 10.1152/ajplung.00440.2020

Table 1.

Patient demographics of RSV positive patients (N = 20)

Range (n) # Mean Median SD
Age
 Controls 0.5–6 mo 10 3.2 3.0 1.83
 RSV 0–7 20 2.0 2.0 1.52
Male
 Controls 6
 RSV 7
Birth weight, kg
 Controls 10 3.65 3.7 0.40
 RSV 20 3.10 3.2 0.84
Ethnicity
 Controls 10
  Caucasian/European 9
  Black or Hispanic 1
 RSV
  Caucasian/European 17
  Black or Hispanic 3
  Secondary bacterial infections 7
Severity of illness scores
 PELOD comprehensive 19 10.70 11.00 3.28
Day 0c 19 8.63 11.00 4.21
  Severe 15 8.87 11.00 4.09
  Moderate 5 7.75 10.00 5.19
Day 3d 19 6.78 11.00 5.45
  Severe 15 7.93 11.00 5.05
  Moderate 5 2.75 0.00 5.50
 PRISMIII 20 2.15 1.5 1.95
  Severe 15 2.13 1.0 2.03
  Moderate 5 2.2 2.0 1.92
PICU LOS, days 20 10.60 10.04 5.56
 Severe 15 11.41 4.86
 Moderate 5 8.56 5.53 7.58
Respiratory support, days
 Mechanical ventilation 15 8.95 7.08 4.30
 High flow oxygen 5 0.96 0.2 1.56

a11/19 patients scored a 1 for PELOD pulmonary score; bpreterm newborn, gestational age 36 completed weeks. LOS, length of stay; PICU, pediatric intensive care unit; RSV, respiratory syncytial virus.